ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
NO
NEXT Oncology at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
NEXT Oncology takes part in 7 sessions at ESMO 2026 in Madrid. Its research centres on early testing of targeted drugs and antibody-drug conjugates in advanced cancers. The studies include drugs directed at KRAS-altered tumors and DLL3-expressing tumors, as well as combinations for pancreatic and lung cancers.
| Organization | ESMO 2026 Attendance |
|---|---|
NO NEXT Oncology San Antonio, TX | |
Early-phase cancer drug trial network with clinical research sites in the United States and Spain. | Poster Fri Oct 23 13:00–15:00 A first-in-human phase 1/2 study of SAR449336, an oral non-covalent pan-KRAS inhibitor, in patients with advanced Kras-mutant solid tumors Gastrointestinal cancersLung & thoracic cancers Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Abstract Sat Oct 24 09:27–09:32 Chair Sat Oct 24 14:45–16:15 Poster Sun Oct 25 12:00–12:45 Talk Tue Oct 27 11:20–11:40 |
Find decision makers at NEXT Oncology
Tell us what you sell and we’ll find the people at NEXT Oncology most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction